Pande Atul
SEC Form 4 insider trading activity
Pande Atul has filed 6 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2026. 6 of those filings fall inside the rolling window. Most recent filing: Aug 28, 2026.
On the most recent filing, Pande Atul is listed as Director at Immunovant, Inc. Inside the rolling window, Pande Atul reported no open-market purchases and 5 open-market sales totaling $425K in IMVT. The largest disclosed transaction in the window is a sale of 6,000 IMVT shares on May 20, 2026, worth $192K.
Companies traded
Other insiders at IMVT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$425K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Pande Atul made?
Pande Atul has filed 6 SEC Form 4 filings (11 transaction rows) across 1 company since 2026.
Which companies does Pande Atul trade?
Pande Atul has filed SEC Form 4 disclosures for 1 company, including IMVT.
When was Pande Atul's most recent SEC Form 4 filing?
Pande Atul's most recent SEC Form 4 filing on Tracefour is dated Aug 28, 2026.
What is Pande Atul's total buy and sell value in the current window?
Inside the rolling retention window, Pande Atul bought $0 and sold $425K based on SEC Form 4 filings.
What was Pande Atul's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 6,000 IMVT shares on 2026-05-20, worth $192K, per SEC Form 4 filings.